The United States is planning to distribute 6.4 million doses of the Pfizer-BioNTech Covid-19 vaccine in the first week after it is cleared for emergency use, which is likely next month.

A committee of the Food and Drug Administration will meet on December 10 to decide whether to green light the medicine, with the US confronted by soaring numbers of deaths and new cases.

Latest figures on Tuesday showed that the country had recorded a total of 259,600 Covid deaths and 12.5 million cases — with over 2,000 deaths and 167,000 new cases in just the last 24 hours.

The chief operations officer for the government’s Operation Warp Speed, General Gustave Perna, told reporters some 40 million doses of vaccine would be available by the end of December.

READ ALSO: Meet Onyeama Ogbuagu, The Nigerian Doctor Involved In COVID-19 Vaccine Development

That figure includes another vaccine developed by Moderna and the National Institutes for Health, which announced some preliminary efficacy results last week and is also close to applying for emergency approval.

The federal government will issue recommendations for who should be prioritized — likely the elderly, high-risk, and frontline workers — but local authorities will make the final decision for themselves.

Vaccinations will begin in retirement homes within 48 hours of the emergency approval, health secretary Alex Azar said. The government has partnered with CVS Health for the retirement home program.

Share:

administrator, person

Leave a Reply

Your email address will not be published. Required fields are marked *